Cite
Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
MLA
Yong-Hong Xu, et al. “Synergy of Nanodiamond–doxorubicin Conjugates and PD-L1 Blockade Effectively Turns Tumor-Associated Macrophages against Tumor Cells.” Journal of Nanobiotechnology, vol. 19, no. 1, Sept. 2021, pp. 1–24. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b50a296c95936f25774e7d31d99b9259&authtype=sso&custid=ns315887.
APA
Yong-Hong Xu, Yan Ma, Zhang Jun Yan Liu, Shi-Kuan Sun, Jinbo Chen, Naoki Komatsu, Yan Liu, Tong-Fei Li, Ke Li, Hua-Zhen Xu, Chao Wang, Li Zhao, Mei-Yan Zheng, & Xiao Chen. (2021). Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells. Journal of Nanobiotechnology, 19(1), 1–24.
Chicago
Yong-Hong Xu, Yan Ma, Zhang Jun Yan Liu, Shi-Kuan Sun, Jinbo Chen, Naoki Komatsu, Yan Liu, et al. 2021. “Synergy of Nanodiamond–doxorubicin Conjugates and PD-L1 Blockade Effectively Turns Tumor-Associated Macrophages against Tumor Cells.” Journal of Nanobiotechnology 19 (1): 1–24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b50a296c95936f25774e7d31d99b9259&authtype=sso&custid=ns315887.